These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 6886480)

  • 1. Isolation rate and toxigenic potential of Clostridium difficile isolates from patients with cystic fibrosis.
    Wu TC; McCarthy VP; Gill VJ
    J Infect Dis; 1983 Jul; 148(1):176. PubMed ID: 6886480
    [No Abstract]   [Full Text] [Related]  

  • 2. Asymptomatic carriage of Clostridium difficile in patients with cystic fibrosis.
    Peach SL; Borriello SP; Gaya H; Barclay FE; Welch AR
    J Clin Pathol; 1986 Sep; 39(9):1013-8. PubMed ID: 3093537
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridium difficile in patients with cystic fibrosis.
    Welkon CJ; Long SS; Thompson CM; Gilligan PH
    Am J Dis Child; 1985 Aug; 139(8):805-8. PubMed ID: 4025261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patients with cystic fibrosis have a high carriage rate of non-toxigenic Clostridium difficile.
    Bauer MP; Farid A; Bakker M; Hoek RA; Kuijper EJ; van Dissel JT
    Clin Microbiol Infect; 2014 Jul; 20(7):O446-9. PubMed ID: 24286342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridium difficile isolation in leukemic children on maintenance cancer chemotherapy. A preliminary study.
    Chiesa C; Gianfrilli P; Occhionero M; Luzzi I; Multari G; Werner B; Pacifico L; Midulla M
    Clin Pediatr (Phila); 1985 May; 24(5):252-5. PubMed ID: 3857141
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Isolation and diagnosis of Clostridium difficile].
    Závadová M; Brezinová L; Bártová M
    Cesk Epidemiol Mikrobiol Imunol; 1987 Dec; 36(6):330-6. PubMed ID: 2961468
    [No Abstract]   [Full Text] [Related]  

  • 7. Isolation of a Clostridium exotoxin producer other than Clostridium difficile from a patient with diarrhea.
    Ravizzola G; Manca N; Dima F; Signorini C; Garrafa E; Turano A
    J Clin Microbiol; 1998 Aug; 36(8):2396. PubMed ID: 9675699
    [No Abstract]   [Full Text] [Related]  

  • 8. Faecal carriage of Clostridium difficile in cystic fibrosis patients.
    Peach SL; Gaya H; Borriello SP
    Ann Ist Super Sanita; 1986; 22(3):953-7. PubMed ID: 3827000
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation rates and toxigenic potential of Clostridium difficile isolates from various patient populations.
    Viscidi R; Willey S; Bartlett JG
    Gastroenterology; 1981 Jul; 81(1):5-9. PubMed ID: 7239125
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxigenic
    Singh M; Vaishnavi C; Kochhar R; Mahmood S
    Indian J Med Res; 2017 Jun; 145(6):840-846. PubMed ID: 29067987
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PCR-ribotyping and pyrolysis mass spectrometry fingerprinting of environmental and hospital isolates of Clostridium difficile.
    Al-Saif NM; O'Neill GL; Magee JT; Brazier JS; Duerden BI
    J Med Microbiol; 1998 Feb; 47(2):117-21. PubMed ID: 9879953
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improved detection of toxigenic Clostridium difficile using the Cepheid Xpert C difficile assay and impact on C difficile infection rates in a tertiary hospital: a double-edged sword.
    Williamson DA; Basu I; Freeman J; Swager T; Roberts SA
    Am J Infect Control; 2013 Mar; 41(3):270-2. PubMed ID: 22939418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden, 1980-1982.
    Aronsson B; Möllby R; Nord CE
    J Infect Dis; 1985 Mar; 151(3):476-81. PubMed ID: 3973405
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Colonization of toxigenic Clostridium difficile among ICU patients: a prospective study.
    Zhang X; Wang X; Yang J; Liu X; Cai L; Zong Z
    BMC Infect Dis; 2016 Aug; 16():397. PubMed ID: 27506470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular characterisation of Czech Clostridium difficile isolates collected in 2013-2015.
    Krutova M; Nyc O; Matejkova J; Allerberger F; Wilcox MH; Kuijper EJ
    Int J Med Microbiol; 2016 Nov; 306(7):479-485. PubMed ID: 27519407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Occurrence of Clostridium difficile infections due to PCR ribotype 027 in Bucharest, Romania.
    Rafila A; Indra A; Popescu GA; Wewalka G; Allerberger F; Benea S; Badicut I; Aschbacher R; Huhulescu S
    J Infect Dev Ctries; 2014 Jun; 8(6):694-8. PubMed ID: 24916866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxin and enterotoxin production by Clostridium difficile.
    Gianfrilli P; Luzzi I; Pantosti A; Occhionero M; Gentile G; Panichi G
    Microbiologica; 1984 Oct; 7(4):375-9. PubMed ID: 6513801
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Demonstration of Clostridium difficile and toxin B in patients at a university clinic].
    Heizmann W; Heeg P; Liebig B; Botzenhart K
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1985 Dec; 182(1):25-32. PubMed ID: 3939049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association of tcdC type and binary toxin status with disease severity and outcome in toxigenic Clostridium difficile.
    Goldenberg SD; French GL
    J Infect; 2011 May; 62(5):355-62. PubMed ID: 21396957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for Clostridium difficile-associated diarrhea among hospitalized adults with fecal toxigenic C. difficile colonization.
    Lin HJ; Hung YP; Liu HC; Lee JC; Lee CI; Wu YH; Tsai PJ; Ko WC
    J Microbiol Immunol Infect; 2015 Apr; 48(2):183-9. PubMed ID: 24064285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.